Adaptive Biotechnologies Corporation (FRA:1HM)

Adaptive Biotechnologies Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,984	2,112	855	642	1,022	3,482
Market Cap Growth	73.98%	147.10%	33.16%	-37.23%	-70.64%	-47.33%
Enterprise Value	1,964	2,109	813	515	747	3,026
Last Close Price	13.47	13.92	6.10	4.76	6.98	23.00
PS Ratio	8.41	8.95	4.94	4.17	5.90	25.66
PB Ratio	10.35	11.02	4.37	2.30	2.35	6.56
P/TBV Ratio	23.75	25.27	11.02	3.85	3.23	8.31
EV/Sales Ratio	8.35	8.94	4.70	3.34	4.31	22.29
Debt / Equity Ratio	0.94	0.94	1.10	0.74	0.50	0.19
Net Debt / Equity Ratio	-0.13	-0.13	-0.16	-0.38	-0.57	-0.76
Net Debt / EBITDA Ratio	0.77	0.77	0.25	0.65	1.48	2.35
Net Debt / FCF Ratio	-	-	0.34	0.70	1.32	1.80
Asset Turnover	0.53	0.53	0.30	0.22	0.21	0.15
Inventory Turnover	18.09	18.09	15.30	13.68	11.84	11.50
Quick Ratio	3.09	3.09	2.71	4.38	4.91	3.27
Current Ratio	3.34	3.34	2.89	4.66	5.12	3.54
Return on Equity (ROE)	-27.82%	-27.82%	-62.49%	-58.34%	-37.52%	-30.77%
Return on Assets (ROA)	-6.79%	-6.79%	-16.18%	-16.60%	-14.06%	-12.81%
Return on Capital Employed (ROCE)	-13.50%	-13.50%	-35.20%	-35.20%	-26.80%	-25.80%
Earnings Yield	-2.55%	-2.40%	-18.03%	-31.75%	-18.32%	-5.23%
FCF Yield	-	-	-11.18%	-23.54%	-18.33%	-6.43%
Buyback Yield / Dilution	-3.14%	-3.14%	-1.88%	-1.31%	-1.54%	-6.96%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.